Analytical considerations to support expeditious formulation development of vaccines
- 1 June 2023
- journal article
- editorial
- Published by Future Science Ltd in Bioanalysis
- Vol. 15 (12) , 653-655
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidateMolecular Therapy - Methods & Clinical Development, 2023
- Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologiesnpj Vaccines, 2022
- Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability dataBiologicals, 2022
- Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch TM Microneedle Delivery SystemHuman Vaccines & Immunotherapeutics, 2021
- Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesHuman Vaccines & Immunotherapeutics, 2021
- Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryJournal of Pharmaceutical Sciences, 2021
- Principles of Vaccine Potency AssaysBioanalysis, 2018
- Vaccine stability study design and analysis to support product licensureBiologicals, 2009
- Error bars in experimental biologyJournal of Cell Biology, 2007